
---
title: '新冠药物、CRO概念再度走弱'
categories: 
 - 新媒体
 - 36kr
 - 快讯
headimg: 'https://picsum.photos/400/300?random=2353'
author: 36kr
comments: false
date: Wed, 26 Jan 2022 01:49:58 GMT
thumbnail: 'https://picsum.photos/400/300?random=2353'
---

<div>   
36氪获悉，新冠药物、CRO概念再度走弱，截至发稿，精华制药连续3跌停，亚太药业、康龙化成、翰宇药业、博瑞医药、舒泰神等跌幅居前。  
</div>
            